The discovery of a new antitrypanosomal hit compound that cures an acute (STIB 900) mouse model of Trypanosoma brucei rhodesiense trypanosomiasis is described. This bis(2-aminoimidazolinium) dicationic compound proved to be an excellent DNA minor groove binder suggesting a possible mechanism for its trypanocidal activity. From these studies, the 4,4'-diaminodiphenylamine skeleton emerged as a good scaffold for antitrypanosomal drugs.
great potential as antitrypanosomal agents. 5 Some of these compounds (Figure 1) showed excellent activity and selectivity (> 3000 for 2a) towards the parasite in vitro, Many agents of the aromatic diamidine 6 or diguanidine class have strong binding affinity for the DNA at AT-rich sites. 7 Some evidence suggests that this interaction may contribute to the antiprotozoal activity frequently associated with this class of compound. Transcription and activity of other DNA-dependent enzymes may all be inhibited by dicationic drugs. 8 In order to gain insight into the mechanism of action of a series of dicationic compounds that we have shown to have profound trypanocidal activity, the DNA binding affinity (i.e., ∆T m values) of the diphenyl (1-5) and aliphatic (6-9) derivatives was measured. Another factor that is essential to the efficacy and selectivity of antitrypanosomal drugs is their effective uptake by the parasite. Dicationic drugs have very slow rates of diffusion across biological membranes and their uptake is dependent on different transporters.
10 Three different transporters have been implicated in the transport of pentamidine: the high and low affinity pentamidine transporters (HAPT and LAPT, respectively whose endogenous substrates are not known) and the P2 aminopurine transporter. 11 The P2 transporter also participates in the uptake of other diamidines (e.g. diminazene, propamidine) and the melaminophenyl arsenicals (e.g. melarsoprol) that bear the common recognition motifs (i.e. amidine moiety, aromatic ring and electronegative heteroatom, Figure 2 ). 12-14 Diphenyl bisguanidines too carry this P2 recognition motif. The loss of the P2 transporter alone appears to be sufficient to render trypanosomes highly resistant to some drugs, for example diminazene. 15 The loss of the transporter also correlates with resistance to melarsoprol, although in this instance additional transporters too must be lost in order to achieve high level resistance. 16 A number of other melamine-based 17 and benzamidine based 18 compounds designed for entry via the P2 transporter also appear to have additional routes into the cell. With regard to understanding about the likelihood of resistance arising to compounds that appear to be substrates for the P2 transporter, it is of importance to know whether uptake is exclusively via this transporter or whether alternative routes into the cell also exist. Thus the most active compounds, 2a and 2b, were also evaluated against a cell line defective in P2 mediated transport to gain information about their possible mechanism of uptake. 
Results and discussion
DNA binding affinity at AT-rich sites. Table 1 presents the results of DNA binding as estimated by ∆Tm measurements (i.e., the difference between the Tm of DNA and the Tm observed in the presence of drug 9 ) with a non-alternating AT sequence DNA polymer. In general, the diphenyl dicationic derivatives showed a strong DNA binding with ∆Tm values in the range of pentamidine for unsubstituted guanidines and 2-aminoimidazolines (1a, 1b, 2a, 2b, 3b, 5a and 5b) whereas substituted guanidines 1c
and 2c had lower values. Differences in binding affinity were observed depending on the bridge linking both phenyl rings: compound 2, with a NH bridge, had higher ∆Tm value than 1 (CH 2 bridge) and 4 (SO 2 bridge). This result could be explained by a better fit of 2 to the minor groove in contrast to 1 and 4 the dihedral angle of which would not be expected to fit the width of the groove. By contrast, compound 3b (CO bridge) bound strongly (27.6 ºC) as expected based on a better fit to the groove. In those series, a good correlation was observed between in vitro activity and DNA binding affinity for the 2-aminoimidazoline compounds (2a > 1a >> 4a) whereas a rough correlation was observed for the guanidine analogues (2b > 3b ~ 1b >> 4b). Indeed, the best trypanocides in vitro, 2a and 2b, were also the best DNA binders of the series (38.5 and 29.6 ºC, respectively).
Moreover, plotting Tm versus IC 50 values against trypanosomes did reveal the two to be correlated for two sets of compounds as shown in Figure 3 . Compounds 4a and 4b
were omitted because they showed no activity which might conceivably relate to their inability to enter cells. Further experiments would be required to test this. In addition, the alkyl dicationic derivatives (6a, 6b-9b) were omitted because there was no correlation between activity and Tm increase. It is likely that there are multiple modes of activity for dications, each of which contributes to the overall IC 50 . In the case of the alkyl group sets an alternative mode of action might mask activity that results from DNA binding.
The nature of the cationic moiety appeared to play a role in the DNA binding affinity of these diphenyl compounds. Compounds with 2-aminoimidazolinium cations had stronger binding than their guanidinium counterparts (compare 1a/1b, 2a/2b and 5a/5b) and two molecules (2a and 5a) bound to DNA with higher affinity than pentamidine.
The more bulky and flexible bis(n-pentylphosphonium) derivative 3f had negligible DNA binding in contrast to its guanidine counterpart. Interestingly, derivatives 5a with 2-aminoimidazolinium cation bind more strongly than its amidine counterpart (N,N'-bis(4-amidinophenyl)piperazine, Figure 2 ) described by Donkor et al. 19 This could relate to the higher basicity of this cation compared to the amidinium or the capacity to form hydrogen bonds. As expected, based on the greater negative potential at the floor of the minor groove in AT rich regions, 20 the uncharged Boc-protected analogue (5e) had insignificant binding. A good correlation between DNA binding affinity and trypanocidal activity was observed with those derivatives (5a> 5b >> 5e) which confirmed the findings of Donkor et al. for this family of conformationally restricted pentamidine congeners. 19 Hence, the mechanism of action of the diphenyl compounds which have strong DNA interaction could be due in part to the formation of a DNA complex.
On the other hand, the alkyl dicationic compounds had much lower affinity than pentamidine, in the range 9.1-14 ºC. This is probably because these derivatives lack the aromatic rings that help to position the cations to interact with A and T bases at the floor of the minor groove. Despite of the low DNA binding, some of these aliphatic molecules (7b, 8b and 9b) showed excellent antitrypanosomal activity in vitro. This could indicate mechanisms of action other than binding to DNA, although it is also noteworthy that dications, including pentamidine and diminazene accumulate to very high levels within trypanosomes, with the mitochondrion in particular concentrating the drug. Thus, even low affinity binding may lead to high overall interactions with kinetoplast DNA at these greatly elevated concentrations. ■ (1b, 1c, 2b, 2c and 3f) and • (1a, 2a, 3b, 5a, 5b and 5e).
In vivo activity. The eight compounds displaying the best in vitro activities and selectivity were then administered intraperitoneally to infected mice to determine whether activity was retained in vivo (Table 2) Unfortunately, no cures were obtained, probably due to a poor BBB penetration of this hit compound. Indeed, this kind of guanidine-like compound has very basic nitrogen atoms that are charged at physiological pH and thus potentially poorly liposoluble and not able to cross the BBB by passive diffusion. Different synthetic strategies exist to improve the pharmacokinetics of cationic compounds such as amidines 21 or guanidines. 22 These pro-drug approaches are currently being studied in our laboratory.
Roles for the P2 transporter in uptake and resistance. Since these compounds carry a motif typical of substrates of the P2 aminopurine transporter, and that loss of this transporter can contribute to the development of resistance to drugs that enter via this route, we evaluated the in vitro activity of 2a and 2b against both the wild type and the TbAT1 knockout line that lacks the P2 transporter. 16 The difference in activity between the two lines for both compounds was small or insignificant (Table 3) . This is similar to results obtained with pentamidine, known to enter via other transporters, 11 but different from diminazene which enters predominantly via the P2 transporter. 15 It has recently been shown that a number of other melamine based 17 and benzamidine-based 18 trypanocides also enter via other transporters in addition to P2. This is significant as it indicates that parasites selected for resistance to drugs through loss of the P2 transporter alone, will not show cross-resistance to these compounds.
Conclusion
We have described a correlation between the DNA binding affinity and trypanocidal activity of two series of diphenyl dicationic derivatives previously found by screening of our in-house library. rhodesiense STIB 900 model, without overt toxicity. Although this compound could not cure the rodent model of CNS infection, probably due to poor BBB penetration, it has potential to be modified (e.g. using a pro-drug approach) in order to improve its CNS delivery. Hence, the 4,4'-diphenylamine scaffold, and 2a in particular, represents a promising dicationic hit compound for the treatment of sleeping sickness.
In this series of bis(2-aminoimidazolinium) diphenyl derivatives, a good correlation between in vitro antitrypanosomal activity and DNA binding was observed, suggesting that this binding could be part of their mechanism of action. Finally, we showed that even though the P2-aminopurine transporter may be involved in the uptake of these hit compounds, this was not the sole route of entry of these guanidine-like compounds into trypanosomes and thus parasites that have lost the P2 transporter in selection of resistance to other drugs will not be cross-resistant to these compounds.
Experimental Section
DNA binding assays. Poly(dA)·poly(dT) was obtained from Pharmacia Corp. and characterized as previously described. 9 Thermal melting experiments were conducted with Cary 300 spectrophotometers interfaced to microcomputers as previously described. 9 A thermistor fixed into a reference cuvette was used to monitor the cell ). 16 The Alamar Blue assay 23 
